Home
About
Overview
Sharing Data
ORCID
Help
History (3)
An Annotated Bibliography of Key Studies in Medical Education in 2018: Applying the Current Literature to Pediatric Educational Practice and Scholarship.
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma.
The potent paracrine effect of umbilical cord mesenchymal stem cells mediates mitochondrial quality control to restore chemotherapy-induced damage in ovarian granulosa cells.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma.
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma. Clin Genitourin Cancer. 2009 Jan; 7(1):39-42.
View in:
PubMed
subject areas
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Papillary
Carcinoma, Renal Cell
Female
Humans
Kidney Neoplasms
Male
Middle Aged
Paclitaxel
Prognosis
Survival Rate
Treatment Outcome